Journal of Musculoskeletal Pain最新文献

{"title":"Other Soft Tissue Pain Conditions","authors":"T. Romano","doi":"10.3109/10582452.2013.795643","DOIUrl":"https://doi.org/10.3109/10582452.2013.795643","url":null,"abstract":"This study purported to identify the results of using ultrasound [US]-guided injections of corticosteroid for biceps brachii tendinitis. This is a randomized prospective study of 98 patients with biceps brachii tendinitis. In Group A, 45 patients were treated by free-hand injection without US guidance and in Group B, 53 patients were treated by US-guided injection. Mean age was 47 years [range 28 to 72 years]. The average follow-up was 33 weeks [range 24 to 56 weeks]. No significant differences between the two groups were noted for age, gender or weight. Thirty-six patients from Group A and 12 patients from Group B underwent repeated injections [p50.5]. Visual analog scale [VAS] score and the Constant-Murley score were used to evaluate outcomes. The VAS score decreased from 7.1 2.3 before injection to 4.2 3.1 at follow-up in Group A and from 6.9 2.6 to 2.1 1.9 in Group B [p50.05]. The Constant-Murley scale improved from 31.4 11.6 before injection to 73.5 19.2 at followup in Group A and from 32.5 14.7 to 85.5 10.3 in Group B [p50.01]. The authors concluded that the US-guided injection group fared better than the group of patients that got free-hand injections. It was important to note that injection therapy was not satisfactory for patients who demonstrated severely frayed tendons at arthroscopy. No complications were noted from the injections in either group. The authors further concluded that the corticosteroid injection under US guidance is a safe and welltolerated procedure.","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"21 1","pages":"196 - 200"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2013.795643","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69495989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Fibromyalgia Syndrome Review","authors":"M. Spaeth","doi":"10.3109/10582452.2013.805178","DOIUrl":"https://doi.org/10.3109/10582452.2013.805178","url":null,"abstract":"Ang DC, Jensen MP, Steiner JL, Hilligoss J, Gracely RH, Saha C: Combining cognitive-behavioral therapy and milnacipran for fibromyalgia: A feasibility randomized-controlled trial. Clin J Pain 2013; epub ahead of print. This study intended to evaluate the feasibility of a randomized-controlled trial and to obtain estimates of the effects of combined cognitive-behavioral therapy [CBT] and milnacipran for the treatment of fibromyalgia syndrome [FMS]. Fifty-eight patients with FMS were randomized to one of the three treatment arms: (1) combination therapy [n1⁄4 20], (2) milnacipranþ education [n1⁄4 19] and (3) placeboþCBT [n1⁄4 19]. Patients received either milnacipran [100 mg/d] or placebo. Patients also received eight sessions of phonedelivered CBT or educational instructions, but only from baseline to week 9. Assessments were conducted at baseline, week 9 and week 21. The primary endpoints were baseline to week 21 changes in weekly average pain intensity and physical function [Short Form-36 physical function scale]. Compared with milnacipran, combination therapy demonstrated a moderate effect on improving SF-36 physical function [SE1⁄4 9.42 (5.48), p1⁄4 0.09, effect size1⁄4 0.60] and in reducing weekly average pain intensity [mean difference (SE)1⁄4 1.18 (0.62), p1⁄4 0.07, effect size1⁄4 0.67]. Compared with milnacipran, CBT had a moderate to large effect in improving Short Form-36 physical function [mean difference (SE)1⁄4 11.0 (5.66), p1⁄4 0.06, effect size 1⁄4 0.70]. Despite the presence of concomitant centrally acting therapies, dropout rate was lower than anticipated [15% at week 21]. Importantly, at least six of the eight phone-based therapy sessions were successfully completed by 89% of the patients and adherence to the treatment protocols was greater than 95%. From these results, the authors conclude that a therapeutic approach that combines phone-based CBT and milnacipran was feasible and acceptable. Moreover, the preliminary data supports conducting a fully powered randomized-controlled trial.","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"21 1","pages":"178 - 182"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2013.805178","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69496646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Fibromyalgia Syndrome in Patients with Nasal Septum Deviation","authors":"M. Ozşahin, H. Yaman, Abdullah Belada, S. Ataoğlu","doi":"10.3109/10582452.2013.795641","DOIUrl":"https://doi.org/10.3109/10582452.2013.795641","url":null,"abstract":"Abstract Objectives: Some studies conducted with patients with obstructive sleep apnea syndrome [OSAS] have suggested an association between sleep-disordered breathing [SDB] and fibromyalgia syndrome [FMS]. Nasal septum deviation [NSD] is a common physical disorder of the nose and it manifests itself with similar complaints, like respiratory distress and headache, as in patients with OSAS. The aim of this study was to determine the frequency of FMS in patients with NSD. Methods: Consecutive patients, 18 to 60 years old, evaluated in an academic otorhinolaryngology outpatient clinic were prospectively recruited for this study. Patients with nasal septal deviation were included in the nasal septum deviation group. Patients without nasal symptom deviation were recruited to serve as controls. All recruited cases were assessed by a single physiatrist for FMS. The FMS diagnosis was made on the basis of the 1990 American College of Rheumatology Research Classification Criteria. Results: One hundred ninety-nine consecutive patients, 18 to 60 years old, were enrolled in the study. Patients were divided into two groups as those with nasal symptom deviation [n = 115] and those without nasal symptom deviation [control group, n = 84]. Fibromyalgia syndrome was diagnosed in six NSD patients [5.2%] and in four [4.8%] control patients. No differences were noted in the prevalence of FMS between the two groups [p = 0.578]. Conclusion: In this study, we demonstrated a normal prevalence of FMS among patients with NSD. Although some studies suggest a relation between sleep disordered breathing and FMS, we could not find any relationship between NSD and FMS. This result may be associated with the fact that patients with OSAS and morbid obesity were excluded from our study. Future studies are warranted to clarify the association between obstructive sleep-disordered breathing and FMS.","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"31 1","pages":"161 - 164"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2013.795641","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69495921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Effects of Self-Efficacy on Depression and Pain in Fibromyalgia Syndrome: Does Initial Depression Matter?","authors":"Charles Van Liew, K. Brown, T. Cronan, S. Bigatti","doi":"10.3109/10582452.2013.797536","DOIUrl":"https://doi.org/10.3109/10582452.2013.797536","url":null,"abstract":"Abstract Objective: Fibromyalgia syndrome [FMS] is a chronic pain condition of unknown etiology. Non-myalgic aspects of the disorder have become increasingly focal in its evaluation. Research has suggested that subgrouping FMS patients based on factors other than pain may abet diagnostic and interventional processes. Self-efficacy and depression are two such constructs that appear to be important in FMS. However, it is not known whether the consequentiality of self-efficacy in FMS is dependent on depression. The present study examined the pathways among depression, self-efficacy and pain, in a large sample of depressed and non-depressed FMS patients over a one-year timeframe to determine whether differential relationships existed. Method: Participants completed assessments of pain intensity, depression and self-efficacy at baseline, 6 months and 1 year as part of an intervention study. Approximately half of the participants met the cutoff for depression in chronic pain populations on the Centers for Epidemiologic Studies Depression Scale. Results: Participants who were depressed at baseline experienced a general decline in pain intensity and depression, whereas depression and pain for non-depressed participants appeared to be far more stable across time. Though self-efficacy was a significant predictor of changes in both pain and depression for depressed participants, self-efficacy did not predict changes in pain for non-depressed participants. Conclusion: Our findings support subgrouping FMS patients based on psychological factors. The results indicated that relationships between pain, depression and self-efficacy differed between depressed and non-depressed participants, implying that individuals with FMS and depression may benefit most from interventions that aim to decrease lability and increase self-efficacy for the most challenging times.","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"23 1","pages":"113 - 125"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2013.797536","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69496825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Gender Differences in Pain Experience and Physical Activity of Fibromyalgia Syndrome Patients","authors":"A. I. Sánchez, M. Valenza, M. P. Martínez, E. Miró, Fabian N. Diener, M. Lami, R. Cáliz","doi":"10.3109/10582452.2013.796036","DOIUrl":"https://doi.org/10.3109/10582452.2013.796036","url":null,"abstract":"Abstract Objectives: To date, very few studies have analyzed gender differences in patients with fibromyalgia syndrome [FMS], as the prevalence of this syndrome is much lower in males than females. The aim of this study was to explore how gender differences affect the experience of pain, physical activity and psychological measures of FMS patients compared to healthy normal controls [HNCs]. Methods: Women and men with FMS were recruited for this study. Demographically matching HNCs were recruited for comparison. A pressure algometer was used to measure patients’ pressure pain thresholds [PPTs]. Participants completed the visual analog scale of the McGill Pain Questionnaire, the Modified Baecke Physical Activity Questionnaire, the Pittsburgh Sleep Quality Index and the Fibromyalgia Impact Questionnaire. Results: Thirty-eight patients with FMS [21 women and 17 men] and 32 HNCs [18 women and 14 men] participated in the study. The PPTs, physical activity and psychological measures showed no significant gender differences between male and female FMS patients [p > 0.05]. Post-hoc analyses showed significant differences in sleep quality and pain intensity between FMS patients and HNCs [p < 0.05]. Regarding physical activity, significant differences were found between men with FMS and healthy men in household activities [p < 0.05]. In women with FMS, sleep quality was negatively correlated with two measures of physical activity [sport and leisure time, p < 0.05]. In men, no significant correlations were found between the measures assessed. Conclusion: These findings suggest that the abnormal nociceptive processing recognized in FMS is similar between genders. As expected, FMS patients rated pain sensations higher on all scales compared to healthy groups. In addition, male and female FMS patients had lower pain thresholds than HNCs. In women with FMS, only sleep quality was significantly correlated with physical activity. Further studies with larger samples are needed to confirm these results.","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"21 1","pages":"147 - 155"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2013.796036","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69496079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Depression, Pain, and Self-Efficacy in Fibromyalgia Syndrome","authors":"I. Russell","doi":"10.3109/10582452.2013.809044","DOIUrl":"https://doi.org/10.3109/10582452.2013.809044","url":null,"abstract":"Perhaps, the most contentious issue in the study of the fibromyalgia syndrome (FMS) has been the role of major depression in its presentation, its natural history and its pathogenesis. Having lost ...","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"21 1","pages":"107 - 112"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2013.809044","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69497258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cauda Equina Syndrome Caused by Lumbar Vertebral Fracture in an Elderly Patient with Ankylosing Spondylitis","authors":"H. Sarı, A. Kaparov, M. Uludağ, Farid Radwan, U. Akarirmak, N. Bozok","doi":"10.3109/10582452.2013.795637","DOIUrl":"https://doi.org/10.3109/10582452.2013.795637","url":null,"abstract":"Abstract Background: Cauda equina syndrome [CES] in patients with ankylosing spondylitis [AS] is an important neurological complication characterized by low back and leg pain, impotence, urinary incontinence, sensory deficits, and motor dysfunction. Vertebral fractures in the course of AS have been found most often in the cervical region, followed in prevalence by the thoracic region but only rarely in the lumbosacral region. Findings: We present an elderly patient with AS who developed spondylolisthesis at the L4–L5 level and CES following a low-energy fracture. Conclusion: Vertebral fractures in course of AS is especially more common in elderly patients with long-standing disease. Early diagnosis and treatment might improve the clinical outcome and might prevent complications.","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"472 1","pages":"173 - 177"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2013.795637","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69496266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Use of Vibration Platforms in Fibromyalgia Syndrome: Future Prospects","authors":"I. Chulvi-Medrano, B. Sañudo, Laura Masiá-Tortosa, M. D. Silva-Grigoletto","doi":"10.3109/10582452.2013.795638","DOIUrl":"https://doi.org/10.3109/10582452.2013.795638","url":null,"abstract":"Abstract Objectives: This review analyzes the information available so as to identify factors influencing whole body vibration training [WBV] and estimates its potential benefits in [FMS]. Finally, we established recommendations [manipulation of variables of vibration stimulus] for applying WBV training in FMS. Findings: We hypothesized that WBV is an effective and safe type of exercise for FMS. We reasoned that the insignificant amount of muscle damage and the minimal voluntary physical effort involved in WBV training could help in the adherence to physical activity in FMS patients. We found WBV could improve physical fitness [strength and balance] and quality of life, along with promoting a decrease of most important signs and symptoms in FMS [fatigue and pain]. Although no dose–response relationship could be observed, training volume might be an important factor for achieving notable improvements. Conclusions: We concluded that our results are important because FMS is a very common rheumatic pathology that affects many women, and WBV training seems to be a very practical type of training which may improve quality of life by improving functional physical fitness and symptoms of FMS.","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"21 1","pages":"165 - 172"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2013.795638","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69496276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Review of: The Phenomenon of Pain by Serge Marchand","authors":"Tamara K. Liller","doi":"10.3109/10582452.2013.795642","DOIUrl":"https://doi.org/10.3109/10582452.2013.795642","url":null,"abstract":"At first glance, The Phenomenon of Pain appears to be a medical textbook. Its initial chapters deftly cover topics of neuroscience and pain in scholarly detail and scope. A closer look reveals that the author, Professor Serge Marchand, PhD, has a more advanced purpose in mind, namely to demonstrate how neurophysiologists and psychologists might benefit from studying the basic tenets of each other’s specialties so that both can more capably treat pain. Dr Marchand notes, ‘‘This approach is quite logical because even if the treatment is ‘psychological,’ knowledge of the neurophysiological mechanisms can only help the therapist to apply it and measure its effects. Similarly, knowledge of factors other than the physiological ones will help the health professional to monitor the patient’s progress and distinguish the effects directly related to the treatment, pharmacological or otherwise, from those related to other internal or external events that may be affecting the patient’’ [pp. 2–3]. He illustrates this point throughout his book, choosing not to concentrate on any one medical condition in detail, offering instead a more general discussion of pain and its treatment. Following detailed, medical chapters on neurophysiology, neurophysiology of pain, and the history/evolution of pain, Dr Marchand introduces the reader to situations where a psychological or societal frame of reference can provide special forms of data or a context in which individuals in pain can be understood. In his chapter on measuring pain, he cautions that, ‘‘. . .it is important to remember that pain is a perception and that physiological measurements reflect nociceptive activity and not necessarily pain’’ and that the ‘‘patient’s assessment is still the standard measurement!’’ [pp. 131–132]. He also discusses in detail many of the concepts and problems inherent in measuring pain from both a physiological and psychological perspective. Not to be missed are later chapters which explore special populations of pain patients. Dr Marchand poignantly describes how in past times the pain perception capabilities of the very young were sometimes grossly underestimated meaning that young infants suffered through painful procedures or illnesses with little or no pain medication. At the other end of the age spectrum, the elderly are particularly vulnerable to the adverse effects of medications, but still need to have their pain addressed. Problems in treating both age groups are difficulties in communication. Also, extremely important in the book is the material on the differences in pain sensitivity and pain tolerance between males and females and between [and within] various racial and ethnic groups. The Phenomenon of Pain is very impressive in all that it covers. It would benefit, though, from a sequel which considers pain not as a single symptom, but one which frequently exists alongside [or in conjunction with] other similarly troublesome, physiological symptoms, such as fatigue, stiff","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"21 1","pages":"201 - 202"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2013.795642","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69495931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Is Fibromyalgia Syndrome Common in the Patients with Primary Dysmenorrhea?","authors":"F. Soyupek, M. Guney, O. Kaplan, D. Doğuç","doi":"10.3109/10582452.2013.795640","DOIUrl":"https://doi.org/10.3109/10582452.2013.795640","url":null,"abstract":"Abstract Objective: To determine the association between fibromyalgia syndrome [FMS] and primary dysmenorrhea [PD]. Methods: Patients with PD formed the PD group and age-matched healthy normal controls were included in the HNC group. The new American College of Rheumatology FMS criteria were used in all patients and depression was assessed with the Beck Depression Inventory [BDI]. Results: There were 45 patients in the PD group and 45 patients in the HNC group. We found FMS in 15.6% of the PD patients and 0.0% of the HNCs. The mean sum of the somatic symptoms was higher in the PD patients with FMS than without FMS. The mean sore of BDI was higher in the PD group than the HNC group, but the mean depression score of the PD patients with FMS was not significantly higher than PD patients without FMS. Conclusions: The frequency of FMS was increased in PD patients, especially in the PD patients who exhibited many somatic symptoms.","PeriodicalId":50121,"journal":{"name":"Journal of Musculoskeletal Pain","volume":"21 1","pages":"156 - 160"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/10582452.2013.795640","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69496381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}